Tamoxifen-induced hepatotoxicity and symptomatic tarlov cyst in a breast cancer survivor — coexistence or consequence?
Year: 2025
Type: article
Study design: Case Report
Abstract: Invasive breast carcinoma is among the most prevalent malignancies affecting women globally. This case presents a 47-year-old female diagnosed with invasive breast carcinoma, treated with mastectomy, chemotherapy, targeted therapy, and hormonal therapy. During follow-up, she developed hepatic dysfunction attributed to tamoxifen and subsequently experienced lower back pain due to a Tarlov cyst. The case underscores the importance of comprehensive and sustained surveillance in breast cancer survivors for the early detection and management of treatment-related complications and musculoskeletal manifestations.
Source: Oncology in Clinical Practice
DOI: 10.5603/ocp.106126
Authors: Omer Esmez, Gulnihal Deniz, Merve Yildiz Esmez
Institutions: Erzurum Technical University, Fırat University
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413958575